Detalhe da pesquisa
1.
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.
Antimicrob Agents Chemother
; 59(8): 4919-29, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055360